Inogen, Inc (NASDAQ:INGN) Analyst Price Target



Inogen, Inc (NASDAQ:INGN): The stock price is expected to reach $ 56 in the short term. The number of analysts agreeing with this consensus is 4. The higher estimate for the short term price target is at $68 while the lower estimate is at $50. The standard deviation of the price stands at $8.29.

Many analysts have commented on the company rating. Equity analysts at the Brokerage firm Stifel Nicolaus maintains its rating on Inogen, Inc (NASDAQ:INGN). The rating major has initiated the coverage with an buy rating on the shares. The Analysts at Stifel Nicolaus raises the price target from $48 per share to $68 per share. The rating by the firm was issued on September 22, 2015.

Analysts at Zacks have given a short term rating of hold on Inogen, Inc (NASDAQ:INGN) with a rank of 3. The company has received an average rating of 1 from 5 brokerage firms. 5 analysts have rated the company as a strong buy.



Inogen, Inc (NASDAQ:INGN) rose 4.05% or 1.97 points on Monday and made its way into the gainers of the day. After trading began at $49.52 the stock was seen hitting $51.12 as a peak level and $48.86 as the lowest level. The stock ended up at $50.58. The daily volume was measured at 392,266 shares. The 52-week high of the share price is $55.98 and the 52-week low is $19.16. The company has a market cap of $984 million.

On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The Securities and Exchange Commission has divulged that Taylor Brenton, officer (EVP, Engineering) of Inogen Inc, had unloaded 3,333 shares at an average price of $53.75 in a transaction dated on September 25, 2015. The total value of the transaction was worth $179,149.

The company shares have rallied 126.09% in the past 52 Weeks. On September 14, 2015 The shares registered one year high of $55.98 and one year low was seen on October 21, 2014 at $19.16. The 50-day moving average is $50.9 and the 200 day moving average is recorded at $42.19. S&P 500 has rallied 0.84% during the last 52-weeks.

Inogen, Inc. (Inogen) is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One systems for the patients who require long-term oxygen therapy. The Companys products include Inogen One G3 and Inogen One G2. The Inogen One G3 and Inogen One G2, weighs at approximately 4.8 and 7.0 pounds, respectively, are amongst the most lightweight portable oxygen concentrators. It markets its product offerings, the Inogen One G3 and the Inogen One G2, as single solutions for oxygen therapy. One G2 is effective for nocturnal use. Its Inogen One G2 and the Inogen One G3 are sub-5 and sub-10 pound portable oxygen.



http://www.otcoutlook.com/inogen-inc-nasdaqingn-analyst-price-target/696933/